Historical Valuation
abrdn Healthcare Investors (HQH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of abrdn Healthcare Investors (HQH) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：18.82
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
abrdn Healthcare Investors (HQH) has a current Price-to-Book (P/B) ratio of 0.77. Compared to its 3-year average P/B ratio of 0.84 , the current P/B ratio is approximately -8.08% higher. Relative to its 5-year average P/B ratio of 0.84, the current P/B ratio is about -8.08% higher. abrdn Healthcare Investors (HQH) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 0.00%, the current FCF yield is approximately NaN% lower. Relative to its 5-year average FCF yield of 0.00% , the current FCF yield is about NaN% lower.
Performance Decomposition
AI Analysis
1Y
3Y
5Y
Market capitalization of HQH increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of HQH in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is HQH currently overvalued or undervalued?
abrdn Healthcare Investors (HQH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of abrdn Healthcare Investors (HQH) is between to according to relative valuation methord.
What is abrdn Healthcare Investors (HQH) fair value?
HQH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of abrdn Healthcare Investors (HQH) is between to according to relative valuation methord.
How does HQH's valuation metrics compare to the industry average?
The average P/S ratio for HQH's competitors is , providing a benchmark for relative valuation. abrdn Healthcare Investors Corp (HQH) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for abrdn Healthcare Investors (HQH) as of Jan 17 2026?
As of Jan 17 2026, abrdn Healthcare Investors (HQH) has a P/B ratio of 0.77. This indicates that the market values HQH at 0.77 times its book value.
What is the current FCF Yield for abrdn Healthcare Investors (HQH) as of Jan 17 2026?
As of Jan 17 2026, abrdn Healthcare Investors (HQH) has a FCF Yield of 0.00%. This means that for every dollar of abrdn Healthcare Investors’s market capitalization, the company generates 0.00 cents in free cash flow.
What is the current Forward P/E ratio for abrdn Healthcare Investors (HQH) as of Jan 17 2026?
As of Jan 17 2026, abrdn Healthcare Investors (HQH) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of abrdn Healthcare Investors’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for abrdn Healthcare Investors (HQH) as of Jan 17 2026?
As of Jan 17 2026, abrdn Healthcare Investors (HQH) has a Forward P/S ratio of 0.00. This means the market is valuing HQH at $0.00 for every dollar of expected revenue over the next 12 months.